Evidence map›Paper›PMID 39816290›Full record

ArticleCureus2024

Severe Symptomatic Anemia as a Rare Initial Manifestation of Type 3 Polyglandular Autoimmune Syndrome: A Case Report.

Hugo Goncalves, Francisco De Oliveira Simões, Rosa Sá, Bárbara Fraga Campos, Rui M Domingues, Narciso Oliveira, Teresa Pimentel

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hugo GoncalvesDivision of Rheumatology, Unidade Local de Saúde de Braga, Braga, PRT.
Francisco De Oliveira SimõesDivision of Internal Medicine, Unidade Local de Saúde de Braga, Braga, PRT.
Rosa SáDivision of Oncology, Unidade Local de Saúde de Braga, Braga, PRT.
Bárbara Fraga CamposDivision of Internal Medicine, Unidade Local de Saúde de Braga, Braga, PRT.
Rui M DominguesInternal Medicine, Hospital de Braga, Braga, PRT.
Narciso OliveiraDivision of Internal Medicine, Unidade Local de Saúde de Braga, Braga, PRT.
Teresa PimentelDivision of Internal Medicine, Unidade Local de Saúde de Braga, Braga, PRT.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autoimmune polyglandular syndrome type 3 (APS-3) is an uncommon condition marked by autoimmune thyroid disease (ATD) linked with other autoimmune issues, excluding Addison's disease. We report a case of a 41-year-old man who was hospitalized due to exhaustion and macrocytic anemia, later diagnosed with APS-3, which included Hashimoto's thyroiditis, pernicious anemia resulting from autoimmune gastritis, and pre-existing vitiligo. Diagnostic results indicated positive intrinsic factor antibodies, a gastric biopsy compatible with gastritis, elevated thyroid peroxidase antibodies, and significant findings from a thyroid ultrasound. Treatment included parenteral vitamin B12, which improved anemia, while for mild hypothyroidism, a watchful waiting approach was taken. This case report highlights the importance of conducting a systematic evaluation of anemia in the diagnosis and management of APS-3. Although anemia is not typically recognized as a characteristic feature of APSs, it can present as pernicious anemia secondary to autoimmune gastritis. These anemias can be significant and severely limiting, often causing pronounced symptoms that greatly impact patients' daily lives, further emphasizing the need for timely diagnosis and appropriate management.

Indexed as

autoimmune gastritisautoimmune polyglandular syndromehashimoto's diseasepoly-autoimmunityvitiligo

Identifiers

PMID39816290
PMCPMC11734642

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.